Literature DB >> 21717211

[Restless legs syndrome and nocturnal leg pain : Differential diagnosis and treatment].

M Hornyak1, K Stiasny-Kolster, S Evers, S Happe.   

Abstract

Pain in the legs belongs to the five most frequent regional pain symptoms. Restless legs syndrome (RLS) presents a particular differential diagnosis for pain in the legs, which is characterized by a nocturnal urge to move the legs often associated with painful sensations in the legs. It is one of the most common neurological disorders and probably the leading cause of nocturnal pain in the legs. In this overview, the diagnosis and therapy of RLS as well as aspects of pain therapy of the disorder are presented. In addition, the differential diagnoses for exclusion of other specific causes of nocturnal pain in the legs are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21717211     DOI: 10.1007/s00482-011-1074-8

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  25 in total

Review 1.  Burning feet syndrome. A clinical review.

Authors:  Ravinder P S Makkar; Anju Arora; Amitabh Monga; Ajay Kr Gupta; Surabhi Mukhopadhyay
Journal:  Aust Fam Physician       Date:  2003-12

2.  Restless legs syndrome prevalence and impact: REST general population study.

Authors:  Richard P Allen; Arthur S Walters; Jacques Montplaisir; Wayne Hening; Andrew Myers; Timothy J Bell; Luigi Ferini-Strambi
Journal:  Arch Intern Med       Date:  2005-06-13

3.  The four diagnostic criteria for Restless Legs Syndrome are unable to exclude confounding conditions ("mimics").

Authors:  Wayne A Hening; Richard P Allen; Mystinna Washburn; Suzanne R Lesage; Christopher J Earley
Journal:  Sleep Med       Date:  2009-01-29       Impact factor: 3.492

4.  Epidemiology of restless legs symptoms in adults.

Authors:  B Phillips; T Young; L Finn; K Asher; W A Hening; C Purvis
Journal:  Arch Intern Med       Date:  2000-07-24

5.  "Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome.

Authors:  J Winkelmann; M Prager; R Lieb; H Pfister; B Spiegel; H-U Wittchen; F Holsboer; C Trenkwalder; A Ströhle
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

6.  Restless legs syndrome: a community-based study of prevalence, severity, and risk factors.

Authors:  B Högl; S Kiechl; J Willeit; M Saletu; B Frauscher; K Seppi; J Müller; G Rungger; A Gasperi; G Wenning; W Poewe
Journal:  Neurology       Date:  2005-06-14       Impact factor: 9.910

Review 7.  Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice.

Authors:  Claudia Trenkwalder; Wayne A Hening; Pasquale Montagna; Wolfgang H Oertel; Richard P Allen; Arthur S Walters; Joao Costa; Karin Stiasny-Kolster; Cristina Sampaio
Journal:  Mov Disord       Date:  2008-12-15       Impact factor: 10.338

8.  Restless legs syndrome is common among female patients with fibromyalgia.

Authors:  Romana Stehlik; Lennart Arvidsson; Jan Ulfberg
Journal:  Eur Neurol       Date:  2008-12-09       Impact factor: 1.710

9.  Does the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem study.

Authors:  Arthur S Walters; William G Ondo; Wen Zhu; Weidong Le
Journal:  J Neurol Sci       Date:  2009-01-23       Impact factor: 3.181

10.  Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.

Authors:  Diego García-Borreguero; Richard P Allen; Ralf Kohnen; Birgit Högl; Claudia Trenkwalder; Wolfgang Oertel; Wayne A Hening; Walter Paulus; David Rye; Arthur Walters; Juliane Winkelmann; Christopher J Earley
Journal:  Sleep Med       Date:  2007-06-01       Impact factor: 3.492

View more
  1 in total

Review 1.  [Perioperative approach to restless legs syndrome].

Authors:  F Bartelke; R Pfister; W Kämmerer
Journal:  Anaesthesist       Date:  2013-12       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.